SG Americas Securities’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
BIP
MA
RHJA
SG Americas Securities's UTMD Position: Q2 2025 in Review
SG Americas Securities sold out of Utah Medical Products (UTMD) in Q2 2025, closing a stake of 3,227 shares — an estimated $181K sold.
SG Americas Securities first reported a position in UTMD in Q3 2014 and held it in 10 quarters. The position peaked at $189K in Q3 2021. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.
- SG Americas Securities reported no remaining Utah Medical Products position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 3,227 Utah Medical Products shares in Q2 2025, an estimated $181K.
- SG Americas Securities first reported a position in Utah Medical Products in Q3 2014 and held it in 10 quarters.
- SG Americas Securities's Utah Medical Products position peaked at $189K in Q3 2021.
- 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.